Categories: HealthcareNews

Healthcare Technology Innovator Appoints Industry Veteran Patrick J. Geraghty to Board of Directors

RICHARDSON, Texas, Aug. 5, 2025 /PRNewswire/ — MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) leader, is proud to announce the appointment of Patrick J. Geraghty to its Board of Directors. Geraghty brings more than three decades of leadership experience in healthcare transformation, innovation, and policy, and currently serves as President and CEO of GuideWell, a $30 billion health solutions enterprise.

“Patrick’s appointment to our board underscores MedeAnalytics’ commitment to bold, strategic leadership,” said Steve Grieco, CEO of MedeAnalytics. “His experience building high-performing, mission-driven healthcare enterprises will be invaluable as we advance our mission to empower our customers to drive healthcare transformation. Our customers appreciate that our Enterprise Health Fabric™, Integrated Analytics and AI, Data Science Factory™, Managed Action™, and Strategic Advisory solutions drive measurable ROI.”

Under Geraghty’s leadership, GuideWell has evolved from a traditional health insurer into a dynamic health solutions organization serving more than 38 million people across the U.S., Puerto Rico, and the Virgin Islands. GuideWell’s portfolio includes Florida Blue, Triple-S Management, GuideWell Health, and other innovative subsidiaries focused on care delivery, behavioral health, and federal program administration.

Geraghty is widely recognized for his strategic vision and commitment to healthcare innovation. He led the restructuring that created GuideWell, a transformation now studied as a capstone business case at Harvard Business School. His leadership has earned GuideWell numerous accolades, including recognition by Fortune, Forbes, Newsweek, and J.D. Power for workplace excellence and member satisfaction.

In addition to his executive role, Geraghty serves as chair of the board for AHIP and holds board positions with the Blue Cross Blue Shield Association, NIHCM, TECO, and the Healthcare Leadership Council. He is also deeply engaged in community initiatives, including the United Way and the MaliVai Washington Youth Foundation.

“I’m excited to join the MedeAnalytics board and contribute to its mission of enabling data-driven transformation across the healthcare ecosystem,” said Geraghty. “MedeAnalytics’ commitment to innovation and integrated solutions is exactly what our industry needs to drive better outcomes, greater value, and improved affordability.”

With Geraghty’s appointment, MedeAnalytics continues to strengthen its leadership team and strategic direction, ensuring the delivery of impactful solutions that empower healthcare organizations to thrive in a rapidly evolving landscape.

About MedeAnalytics
With over 30 years as a healthcare technology leader, MedeAnalytics provides the most powerful enterprise data enrichment platform and analytics solutions specifically built for healthcare. By harnessing the first fully curated, turnkey Health Fabric™, combined with Strategic Advisory services and artificial intelligence through our Data Science Factory™, its scalable, seamless and transformational SaaS solutions enable measurable and transparent ROI via its Managed Action™ ecosystem. To learn more, visit MedeAnalytics’ website, LinkedIn, and explore its featured insights.

Media Contact:
Jeff Rusack
Media Relations Manager
JRusack@knbcomm.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthcare-technology-innovator-appoints-industry-veteran-patrick-j-geraghty-to-board-of-directors-302521273.html

SOURCE MedeAnalytics

Staff

Recent Posts

Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement

Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 4, 2026) - Izotropic Corporation (CSE:…

56 minutes ago

INTURAI VENTURES LAUNCHES NEW CAPABILITIES FOR HEALTHCARE AND SURVEILLANCE USING STANDARD WIRELESS SIGNALS

(CSE: URAI  / OTC: URAIF / FSE: 3QG0)investor@inturai.comHighlightsInternally developed processes enable biometric sensing and health…

3 hours ago

Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform

Montreal, Quebec--(Newsfile Corp. - February 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB:…

5 hours ago

In HelloNation, Immigration Attorney Maleeha Haq of Newark, CA, Explains How the Asylum Process Works for Immigrants

NEWARK, Calif., Feb. 3, 2026 /PRNewswire/ -- What steps must immigrants take to navigate the…

9 hours ago

Medexus Schedules Third Fiscal Quarter 2026 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 3, 2026) - Medexus Pharmaceuticals (TSX: MDP)…

15 hours ago

In HelloNation, Family Counseling Expert Scott Ostrowski of Geneva Outlines Employee and Employer Support Services for HelloNation

GENEVA, N.Y., Feb. 3, 2026 /PRNewswire/ -- What are Employee and Employer Support Services, and…

15 hours ago